Sherko Kuemmel

Breast Centre, Kliniken Essen Mitte Essen Germany · Breast Centre, Kliniken Essen Mitte · KEM, Clinics Essen-Mitte

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Sherko Kuemmel as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:23 UTC. Open this list on ClinicalTrials.gov

Ph3
NCT07242352 · Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC
Women's Cancer Study Group GmbH · recruiting · Breast Cancer, HR+/HER2- Breast Cancer · principal investigator
Ph3
NCT07178730 · NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer
Women's Cancer Study Group GmbH · not yet recruiting · Breast Cancer, Triple-negative Breast Cancer · principal investigator
Ph3
NCT06081244 · NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
Women's Cancer Study Group GmbH · recruiting · Triple Negative Breast Cancer · principal investigator
N/A
NCT05792150 · PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Women's Cancer Study Group GmbH · recruiting · Female Breast Cancer · principal investigator
Ph2
NCT05704829 · NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
Women's Cancer Study Group GmbH · recruiting · HER2-positive Early Breast Cancer · principal investigator
N/A
NCT05462457 · TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes
Kliniken Essen-Mitte · recruiting · Breast Cancer, Node-positive Breast Cancer · study chair
N/A
NCT04468113 · Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy
Kliniken Essen-Mitte · completed · Primary Breast Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:23 UTC. The ranking covers the 200 most relevant of 50 PubMed records, and a shared surname and initials can bring in a namesake. All 50 on PubMed